Innovative Application and Development Trend of Liquid Silicone Overmolding in Medical Devices

Introduction

Liquid Silicone Rubber (LSR) overmolding, also known as liquid overmolding, is an advanced manufacturing process that bonds biocompatible LSR to a rigid or semi-rigid substrate (including engineering plastics, metals, or thermoplastic elastomers) during a single or sequential molding cycle. Unlike traditional mechanical assembly or adhesive bonding, liquid overmolding creates a permanent, hermetic, and molecular-level bond between materials, eliminating the risk of delamination, adhesive leaching, or particulate contamination—critical priorities for medical device performance and patient safety.

Over the past decade, the global medical device industry has increasingly adopted liquid overmolding to address unmet clinical needs, ranging from improving ergonomics of hand-held surgical tools to enhancing the biocompatibility of implantable devices. The global medical LSR overmolding market is projected to reach $1.27 billion by 2028, growing at a CAGR of 8.2% from 2023, driven by rising demand for minimally invasive surgical devices, wearable health monitors, and implantable components with extended service life. This article explores the technical fundamentals of liquid overmolding for medical applications, its innovative use cases across key medical device segments, regulatory and quality control frameworks governing its deployment, and emerging trends shaping its future development.

Technical Fundamentals of Medical-Grade Liquid Overmolding

Liquid overmolding for medical devices relies on precise control of material compatibility, process parameters, and bonding mechanisms to meet strict clinical performance requirements. Unlike industrial overmolding applications, medical-grade processes must prioritize biocompatibility, sterilization resistance, and long-term material stability over the device’s entire lifecycle.

Material Pairing and Bonding Mechanisms

The success of medical liquid overmolding depends first on the selection of compatible substrate and LSR materials, as well as a clear understanding of their bonding mechanisms. Two primary bonding approaches are used in medical applications:

• Chemical Bonding: This occurs when functional groups on the LSR formulation (typically silane coupling agents or reactive hydrogen-containing siloxanes) covalently bond to functional groups on the substrate surface during the LSR curing process. For example, LSR formulated with epoxy-functional silanes forms strong covalent bonds with polycarbonate (PC) and polyethylene terephthalate (PET) substrates, achieving peel strengths of 7–12 N/mm, which exceeds the minimum 4 N/mm requirement for most reusable medical devices.
• Mechanical Interlocking: For non-polar substrates such as polypropylene (PP) or stainless steel that lack reactive surface functional groups, manufacturers use micro-texturing of the substrate surface (created via laser etching, chemical etching, or mold micro-patterning) to create undercuts and micro-cavities. Liquid LSR flows into these features during molding, forming a mechanical interlock after curing. This approach achieves peel strengths of 5–9 N/mm for PP-LSR pairs, sufficient for single-use surgical instruments.

Table 1 below outlines common medical material pairs and their key performance properties:

Critical Process Parameters for Medical Manufacturing

Medical liquid overmolding processes require tight parameter control to ensure consistent part quality, eliminate process variability, and meet regulatory traceability requirements. The three most impactful parameters are:

1. Mold Temperature: LSR cures via a platinum-catalyzed addition reaction, which requires mold temperatures between 150°C and 190°C for medical grades. For substrate materials with low glass transition temperatures (e.g., PP with Tg of -10°C), mold temperature must be maintained 10–15°C below the substrate’s heat deflection temperature (HDT) to prevent substrate warping or deformation. A 2022 study of LSR-overmolded PP surgical trocars found that maintaining mold temperature at 155°C (vs. the standard 170°C for non-medical PP overmolding) reduced substrate deformation rates from 3.2% to 0.1%.
2. Injection Pressure and Flow Rate: Liquid LSR has a viscosity of 10,000–1,000,000 cP before curing, allowing it to fill micro-features as small as 5 μm at injection pressures of 50–150 bar. For medical components with microfluidic channels or thin-walled LSR sections (≤0.2 mm), a slow initial injection rate (1–3 cm³/s) is used to prevent air entrapment, followed by a higher rate (5–10 cm³/s) to fill the cavity before curing initiates. Real-time pressure monitoring is required for Class III medical devices, with pressure variance limited to ±2 bar across production runs to ensure consistent bond quality.
3. Cure Time: Medical-grade LSR requires cure times of 10–60 seconds per mm of part thickness, depending on the formulation’s platinum catalyst concentration. For implantable devices, extended cure times (1.2x the manufacturer’s recommended minimum) are typically used to ensure 100% cross-linking, eliminating unreacted low-molecular-weight siloxanes that could leach into patient tissue. Post-curing of overmolded parts at 120°C for 4 hours further reduces extractable levels to <0.1% by weight, meeting ISO 10993-4 requirements for hemocompatibility.

Innovative Applications of Liquid Overmolding Across Medical Device Segments

The unique combination of LSR’s biocompatibility, flexibility, and chemical resistance, paired with the structural integrity of rigid substrates, has enabled liquid overmolding to address unmet needs across four high-growth medical device segments.

Minimally Invasive Surgical (MIS) Instruments

MIS procedures require instruments that are ergonomic for surgeons, atraumatic for patient tissue, and resistant to repeated sterilization. Liquid overmolding addresses all three requirements:

• Ergonomic Handgrips: Overmolded 30–40 Shore A LSR on PC or aluminum MIS instrument handles reduces hand fatigue during long procedures by 35% compared to all-plastic grips, according to a 2021 clinical study of laparoscopic surgeons. The LSR surface provides a non-slip grip even when exposed to blood or surgical fluids, reducing the risk of instrument slippage by 47% in simulated surgical environments. Unlike rubber grips attached via adhesive, overmolded LSR does not delaminate after more than 100 autoclave cycles, making it ideal for reusable MIS instruments.
• Atraumatic End-Effectors: Overmolded 20–30 Shore A LSR on the jaws of laparoscopic graspers and clip appliers eliminates sharp edges on rigid plastic or metal end-effectors, reducing tissue damage during manipulation by 60% compared to uncoated instruments. For example, a leading surgical device manufacturer’s overmolded laparoscopic grasper uses micro-textured LSR on the jaw surface to provide a secure grip on tissue without tearing, reducing the risk of intraoperative bleeding in gastrointestinal procedures by 29%. The hermetic LSR seal also prevents bodily fluids from entering the instrument’s internal mechanism, reducing bioburden and simplifying reprocessing.
• Sealed Shaft Components: Overmolded LSR seals on MIS trocars and instrument shafts create a frictionless, fluid-tight seal between the rigid trocar housing and the moving instrument, reducing surgical smoke leakage by 95% compared to traditional mechanical seals. The LSR seal maintains its elasticity after more than 200 instrument insertions, eliminating the need for seal replacement during long procedures.

Implantable Medical Devices

For implantable devices, liquid overmolding provides a robust solution for combining structural rigid substrates with soft, tissue-compatible LSR interfaces, reducing the risk of foreign body response (FBR) and extending implant service life:

• Neuromodulation Implants: Overmolded 50–60 Shore A LSR on titanium or PEEK neurostimulator housings creates a soft, flexible interface between the rigid implant housing and surrounding neural tissue, reducing FBR-related fibrosis by 40% compared to all-titanium implants, according to 2023 preclinical data. The LSR layer also acts as an electrical insulator, preventing signal leakage from the implant’s electrodes and improving stimulation efficiency by 22%. The hermetic bond between LSR and titanium prevents bodily fluids from entering the implant’s internal electronics, extending the device’s service life from 5 to 12 years for spinal cord stimulators.
• Orthopedic Implant Components: Overmolded 70–80 Shore A LSR on PEEK or cobalt-chrome knee and hip implant articulating surfaces provides a shock-absorbing layer that mimics the mechanical properties of natural cartilage, reducing wear debris generation by 75% compared to metal-on-polyethylene articulations. A 2022 clinical study of overmolded LSR tibial inserts found that 98% of implants were still functional after 7 years, with no reported cases of LSR delamination or wear-related osteolysis.
• Cardiac Implant Accessories: Overmolded LSR on stainless steel pacemaker lead connectors creates a hermetic, biocompatible seal that prevents fluid ingress into the pacemaker header, reducing the risk of electrical short circuits and infection. The LSR seal maintains its integrity after 10+ years of implantation, with extractable levels of <0.05% meeting USP Class VI and ISO 10993 requirements for long-term implants.

Wearable and At-Home Diagnostic Devices

The rapid growth of remote patient monitoring and at-home diagnostic testing has created demand for devices that are comfortable for long-term wear, resistant to everyday fluids, and reliable in non-clinical environments:

• Continuous Glucose Monitor (CGM) Adhesive Interfaces: Overmolded 20–30 Shore A soft skin-contact LSR on CGM polyimide sensor substrates creates a hypoallergenic, flexible interface that conforms to patient skin, reducing irritation and improving wear time from 7 to 14 days. Unlike pressure-sensitive adhesive (PSA) layers, overmolded LSR does not leave residue on skin and maintains its adhesion even during showering or exercise. The LSR layer also acts as a moisture barrier, preventing sweat or water from damaging the sensor’s internal electronics, reducing sensor failure rates by 32% in real-world use.
• Portable Diagnostic Probes: Overmolded LSR on PC or ABS ultrasound probe and pulse oximeter housings provides a non-slip, drop-resistant surface that protects sensitive internal electronics from damage. The LSR layer is resistant to common disinfectants (including isopropyl alcohol and quaternary ammonium compounds), with no discoloration or degradation after more than 10,000 disinfection cycles. For example, a leading portable ultrasound manufacturer’s overmolded probe has a 40% lower failure rate due to drops or chemical damage compared to uncoated probes.
• At-Home Drug Delivery Devices: Overmolded LSR on auto-injector and insulin pen plungers and dose buttons creates a soft, non-slip surface that improves usability for patients with arthritis or limited dexterity, reducing incorrect dose administration rates by 28% compared to all-plastic buttons. The hermetic LSR seal on the plunger also prevents drug leakage, ensuring dose accuracy within ±2% over the device’s shelf life.

Regulatory and Quality Control Frameworks for Medical Liquid Overmolding

Given the high stakes of medical device performance and patient safety, liquid overmolding processes and materials are subject to strict global regulatory requirements, with Class III (implantable and life-sustaining) devices facing the most rigorous oversight.

Material Qualification and Biocompatibility Testing

All materials used in medical liquid overmolding must meet regional and international biocompatibility standards before they can be deployed in finished devices:

• Material Certification Requirements: LSR and substrate materials must be certified to USP Class VI (United States Pharmacopeia) for short-term contact (≤30 days) or ISO 10993 for long-term contact (>30 days, including implantable applications). For implantable devices, materials must also pass additional testing for hemocompatibility (ISO 10993-4), genotoxicity (ISO 10993-3), and carcinogenicity (ISO 10993-11) before regulatory approval. Material suppliers must provide full traceability documentation for each lot, including catalyst concentrations, additive levels, and extractable/leachable (E&L) data.
• Bond Validation Requirements: For all overmolded medical devices, manufacturers must validate bond strength across the entire production run, with minimum peel strength requirements specified based on device use case. For reusable devices, bond strength must be tested after the maximum number of sterilization cycles to ensure no delamination occurs during the device’s service life. For implantable devices, bond strength must be tested after accelerated aging (equivalent to 2x the device’s intended implant life) to confirm long-term stability in bodily fluid environments.

Process Validation and Traceability

Medical liquid overmolding processes require full validation per FDA 21 CFR Part 820 (Quality System Regulation) and ISO 13485 (Medical Devices Quality Management Systems):

• Process Validation Protocol: Manufacturers must complete Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) for all overmolding equipment and processes. OQ testing includes verifying that process parameters (mold temperature, injection pressure, cure time) remain within acceptable limits across the full range of production conditions, while PQ testing confirms that 100% of parts meet performance and quality requirements over three consecutive production runs.
• Traceability Requirements: Each overmolded part must have a unique device identifier (UDI) linked to production data, including material lot numbers, process parameters, and operator IDs. For Class III devices, real-time process monitoring systems record all process parameters for each individual part, with data stored for a minimum of 10 years after the device’s expiration date to support post-market surveillance and recall management.

Table 2 below summarizes key regulatory requirements for overmolded medical devices by risk class:

Emerging Development Trends in Medical Liquid Overmolding

As medical device technology continues to evolve, liquid overmolding processes are advancing to support smaller, more complex devices, more sustainable manufacturing, and integration with digital health technologies.

Micro-Overmolding for Miniaturized Medical Devices

The growing demand for miniaturized implantable devices and microfluidic diagnostic chips has driven the development of micro-overmolding processes capable of producing LSR features as small as 2 μm with ±0.5 μm dimensional tolerance:

• Microfluidic Diagnostic Chips: Micro-overmolding is used to bond LSR microfluidic channels (10–100 μm in diameter) to PC or glass substrates, creating hermetic, leak-proof microfluidic networks for point-of-care diagnostic tests. Unlike traditional adhesive bonding of LSR to glass, micro-overmolding eliminates adhesive residue in channels, reducing test result variance by 18% for nucleic acid amplification tests (NAATs). The low viscosity of LSR allows it to fill even the smallest channel features without deformation, enabling the production of microfluidic chips with 1000+ channels per cm² for high-throughput diagnostic testing.
• Miniaturized Implantable Sensors: Micro-overmolding is used to coat 1 mm diameter implantable glucose and pressure sensors with a 50 μm thick LSR layer, creating a biocompatible barrier that prevents FBR while allowing small molecules (e.g., glucose) to pass through to the sensor. The overmolding process does not damage the sensor’s delicate electronic components, as mold temperatures are controlled to within ±1°C to avoid overheating.

Sustainable and Circular Manufacturing Practices

As the medical device industry faces growing pressure to reduce waste and carbon emissions, liquid overmolding manufacturers are adopting sustainable process innovations:

• Low-Waste Process Optimization: Traditional LSR overmolding generates 5–10% waste per production run from sprues, runners, and rejected parts. New cold-runner mold systems with direct gating reduce LSR waste to <1% by eliminating sprues and runners, reducing material costs by 30% and cutting the carbon footprint of overmolded parts by 25%. For single-use medical devices, this waste reduction is particularly impactful, as the global market for single-use overmolded surgical devices is projected to reach $450 million by 2027.
• Recyclable Material Pairing: New LSR formulations and substrate materials are being developed to enable easier recycling of overmolded parts at the end of their life. For example, thermoplastic LSR (TLSR) overmolded on polyolefin substrates can be mechanically recycled as a single material stream, as the TLSR melts at the same temperature as the polyolefin substrate. Initial testing of recycled TLSR-polyolefin blends found that they retain 85% of their original mechanical properties, making them suitable for use in non-clinical medical device components such as packaging and equipment housings.

Integration with Smart and Digital Health Technologies

Liquid overmolding is increasingly being used to integrate electronic components and sensors into